Neuroendocrine Tumors - Imaging Study

Imaging of Neuroendocrine Tumors with PETand Fluor-18-Dopa (F-DOPA)

Protocol ID

03-117

Protocol Description

The purpose of this research study is to evaluate the use of PET scanning (Positron Emission Tomography) to localize a neuroendocrine tumor (such as carcinoid, pheochromocytoma, medullary carcinoma of the thyroid, or other types) with a radiotracer.  A neuroendocrine tumor is a type of tumor that produces and secretes chemical substances that can make you feel sick. The neuroendocrine tumor may cause symptoms such as diarrhea and/or redness of the skin (flushing) or high blood pressure in some patients with pheochromocytoma, or other symptoms according to the type of neuroendocrine tumor.  A radiotracer is a radioactive chemical that is injected into the bloodstream in very small amounts and will serve as an indicator of the presence of the tumor. 

Eligibility Criteria

Patients who have been clinically diagnosed with neuroendocrine tumor(s) and lesions that were either detected or not detected on a previous OctreoScan performed as part of standard care

Primary Investigator(s)

  • Yena Studentsova, MD

Contact Information

Yena Studentsova, MD
(516) 562-2844
ystudent@nshs.edu

Last Update

April 12, 2010
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Neurosciences:
top